Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (Q77163010)
Jump to navigation
Jump to search
scientific article published on 01 September 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase |
scientific article published on 01 September 1998 |
Statements
Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (English)
P Gaynon
O Ek
T Zeren
L M Chelstrom
1 September 1998